The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded an indefinite delivery contract to Bio-Medical Applications Of Oklahoma, Inc., division Fresenius Medical Care-North America, doing business as Oklahoma Acute Services, to provide inpatient dialysis services on-site at the VA Medical Center in Muskogee, Oklahoma. The contract has a potential value of $335,221 and period of performance through January 31, 2022. Two firm fixed price delivery orders have been awarded against this contract. The first, awarded April 13, 2021, was for $154,820 to provide dialysis services from April 13, 2021 through September 30, 2021. The second, awarded October 1, 2021, was for $29,860 to provide dialysis services from October 1, 2021 through January 31, 2022. Both delivery orders were awarded without a set-aside designation. The place of performance for the contracted dialysis services is the VA Medical Center located in Muskogee, Oklahoma. The original solicitation sought to procure inpatient dialysis services at this facility to support healthcare programs for veterans served by the VA network. The prime contractor, Bio-Medical Applications of Oklahoma, Inc., will deliver the requested dialysis treatment to meet the medical needs of veterans at this location.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00001 | Exercise an Option | $0 | 8/26/21 | |
| Not listed | Not listed | $0 | 4/13/21 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36C25921D0044-36C25922N0015 | Bio-Medical Applications Of Oklahoma, Inc. | $29.9k | 10/1/21 | 1/31/22 | 2/9/23 | |
Delivery Order 36C25921D0044-36C25921N0306 | Bio-Medical Applications Of Oklahoma, Inc. | $154.8k | 4/13/21 | 9/30/21 | 2/9/23 |